Ayuko Ota-Setlik

发表

Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection

J. Weiner, C. Bailey-Kellogg, D. Montefiori, 2019, Molecular systems biology.

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial

Shuying S Li, M. McElrath, J. McElrath, 2018, PloS one.

The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses

M. Egan, K. Bagley, Jennifer A. Schwartz, 2015, Human vaccines & immunotherapeutics.

Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge

T. Rudge, C. Sabourin, J. Eldridge, 2017, Journal of Virology.

Single dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

J. Eldridge, C. Mire, D. Clarke, 2015, Nature.

Oxidant Preconditioning Protects Human Proximal Tubular Cells against Lethal Oxidant Injury via p38 MAPK and Heme Oxygenase-1

H. Lee, C. Emala, Hua Xu, 2003, American Journal of Nephrology.

Differential Protective Effects of Volatile Anesthetics against Renal Ischemia–Reperfusion Injury In Vivo

S. Nasr, H. Lee, C. Emala, 2004, Anesthesiology.

Local anesthetics worsen renal function after ischemia-reperfusion injury in rats.

V. D’Agati, H. Lee, C. Emala, 2004, American journal of physiology. Renal physiology.

Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death

H. Feldmann, C. Happi, J. Eldridge, 2019, The Journal of clinical investigation.

Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial.

J. Eldridge, Susan E. Witko, D. Clarke, 2020, The Lancet. Infectious diseases.

A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure.

V. D’Agati, H. Lee, M. Jacobson, 2003, American journal of physiology. Renal physiology.

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Charles Y. Tan, P. Dormitzer, K. Swanson, 2021, Nature.

CORRELATION OF PRO-APOPTOTIC URINARY MARKERS WITH SURGICAL PROCEDURE ASSESSMENT SCORE IN CARDIAC SURGICAL PATIENTS

Rajeev Joshi, H. Playford, R. Sladen, 2003 .

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus

H. Feldmann, A. Marzi, J. Eldridge, 2015, The Journal of infectious diseases.

BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2

Charles Y. Tan, P. Dormitzer, K. Swanson, 2020, bioRxiv.

An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model

W. Halford, J. Eldridge, H. Andersen, 2017 .

Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers

S. Russell, K. Peng, J. Eldridge, 2018, Molecular therapy oncolytics.

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA

R. Gottardo, N. Frahm, Greg Finak, 2017, Clinical and Vaccine Immunology.

failureischemia- and myoglobinuria-induced renal adenosine receptor knockout mice are protected

V. D’Agati, H. Lee, M. Jacobson, 2016 .

An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model.

W. Halford, H. Andersen, K. Bagley, 2017, Viral immunology.